How much do companies pay doctors in connection with Abiraterone?

Across Open Payments program years 2019–2025, manufacturers reported $159,609 in payments to 10 U.S. providers naming Abiraterone, across 89 separate transactions — an average of $1,793 per transaction. Most reported payments nationally are meals worth under $20.

Does being paid in connection with Abiraterone mean a doctor is promoting it?

Not necessarily. Manufacturers must report the product associated with almost every transfer of value, including a meal provided during a presentation about that product. Consulting, speaking and research arrangements are also reported this way. The disclosure records an association, not a motive.

Abiraterone: cost and payments to doctors

What Medicare Part D paid pharmacies for Abiraterone, and the payments that named it as the associated drug or biological under the Sunshine Act for program years 2019–2025.

Part D cost for Abiraterone formulations

Medicare reports Abiraterone under its specific formulations, which are priced separately.

abiraterone acetate$1,675per 30-day fill · 360,226 claims · Abiraterone Acetate

Paid to pharmacies by Part D plans and patients — not your cost, and not paid to the prescriber. Is this wrong?

Was your doctor paid by Hikma Pharmaceuticals USA?

Hikma Pharmaceuticals USA reported the most payments naming Abiraterone. Search your clinician to see whether they are among them — and what else they were paid for.

Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.

Total reported: $160K
Providers: 10
Transactions: 89
Average per transaction: $1,793

The per-transaction average — $1,793 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 10 providers the average total is $15,961, but that average hides a very steep distribution.

Companies reporting these payments

Company	Total reported	Share
Hikma Pharmaceuticals USA	$159,609	100.0%

Other products from Hikma Pharmaceuticals USA

The company that reported the most payments naming Abiraterone also reports against these.

OXYCODONE HYDROCHLORIDE$1,248,969
MORPHINE SULFATE$1,247,847
OXYMORPHONE HYDROCHLORIDE$1,247,847
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE$544,526
Buprenorphine HCL$544,526
Buprenorphine & Naloxone$409,223
Buprenorphine$409,223
Ryaltris$285,041
VALRUBICIN INTRAVESICAL SOLUTION$247,608
Dasatinib$198,775

← All drugs & devices